Premium
Effect of renal impairment on the pharmacokinetics of a new dopaminergic selective anti‐psychotic compound (sertindole)
Author(s) -
Wong S.L.,
Scbree T.,
Menacherry S.,
Mulford D.,
Linnen P.,
Granneman G.R.
Publication year - 1996
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/sj.clpt.1996.242
Subject(s) - sertindole , clinical pharmacology , pharmacokinetics , pharmacology , medicine , dopaminergic , perphenazine , antipsychotic , schizophrenia (object oriented programming) , psychiatry , dopamine
Clinical Pharmacology & Therapeutics (1996) 59 , 186–186; doi: 10.1038/sj.clpt.1996.242
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom